Understand the prescription, the pigment concern and the plan around it. Seven brands, reviewed to support a better-informed next conversation.
CoreAge Rx has first commercial placement. This is a curated comparison of prescribing services, a labeled prescription drug and a cysteamine cream—not a clinical league table.
Exact concentrations and treatment duration need individual confirmation.
The Spot Cream is marketed for melasma and other pigment concerns.
Patient-reported outcomes do not replace controlled comparative evidence.
Dark Spot Rx is a customized pigment treatment, with hydroquinone-free formulas also possible.
Not every formula contains hydroquinone; the brand name is not a fixed recipe.
A fixed three-drug cream with a specific short-term facial-melasma indication.
Not indicated for maintenance; the label has important population and use limits.
Studies of older 5% preparations are not automatically trials of today’s 7% formula.
Discoloration Defense publishes four highlighted ingredient percentages.
Appearance studies are not a head-to-head melasma treatment ranking.
Dark-spot marketing is not a diagnosis or a prescription treatment claim.
The named blend, current starting price and prescribing questions behind CoreAge Rx’s pigment cream.
A personalized pigment-treatment family whose exact prescription and renewal deserve a closer look.
A custom pigment treatment with several possible active ingredients and a specified 60-day supply.
A current 7% cysteamine rinse-off cream, with older clinical research kept in its proper context.
The four published percentages are useful, but the finished serum and its study context matter more than a single ingredient name.
What the US Thiamidol serum discloses, what the package needs to confirm, and why a dark-spot headline is not a melasma outcome.
Compare SkinCeuticals and Eucerin without mistaking cosmetic claims for a diagnosis, a prescription or a guarantee of clearance.
A shared color does not mean two pigment concerns need the same cream.
A cream comparison is incomplete without the protection used around treatment.
The ingredient, formulation and treatment window belong in the same conversation.
Understand why trial concentration, comparator and outcome matter to a product review.
Improvement is a reason to review the plan, not automatically continue every active indefinitely.
We read product pages, published research, and regulatory guidance. We explain the tradeoffs, distinguish marketing from evidence, and link the sources so you can look closer.
Read our methodology